Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value
$2.86−0.14 (-4.67%)
Close on Nov 13, 2026Market cap $122.83MP/E –Yield –
Pulmonx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pulmonx's profit margin for the twelve months ending Sep 30, 2026 was -47.9%. For fiscal 2025 it was -59.7%, against -67.3% the year before. The highest annual figure on record is -59.7% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -59.7% | +7.6 |
| FY2024 | Dec 31, 2024 | -67.3% | +21.3 |
| FY2023 | Dec 31, 2023 | -88.6% | +21.2 |
| FY2022 | Dec 31, 2022 | -109.8% | −9.3 |
| FY2021 | Dec 31, 2021 | -100.5% | −2.0 |
| FY2020 | Dec 31, 2020 | -98.5% | −35.0 |
| FY2019 | Dec 31, 2019 | -63.5% | +28.9 |
| FY2018 | Dec 31, 2018 | -92.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -36.8% | +28.2 |
| Q2 FY2026 | Jun 30, 2026 | -44.3% | +19.3 |
| Q1 FY2026 | Mar 31, 2026 | -66.3% | −2.2 |
| Q4 FY2025 | Dec 31, 2025 | -46.1% | +9.3 |
| Q3 FY2025 | Sep 30, 2025 | -64.9% | +4.5 |
| Q2 FY2025 | Jun 30, 2025 | -63.6% | +10.1 |
| Q1 FY2025 | Mar 31, 2025 | -64.1% | +8.8 |
| Q4 FY2024 | Dec 31, 2024 | -55.4% | +16.6 |
| Q3 FY2024 | Sep 30, 2024 | -69.4% | +15.0 |
| Q2 FY2024 | Jun 30, 2024 | -73.7% | +20.4 |
| Q1 FY2024 | Mar 31, 2024 | -72.9% | +36.2 |
| Q4 FY2023 | Dec 31, 2023 | -72.0% | +20.6 |
| Q3 FY2023 | Sep 30, 2023 | -84.3% | +20.6 |
| Q2 FY2023 | Jun 30, 2023 | -94.2% | +10.8 |
| Q1 FY2023 | Mar 31, 2023 | -109.1% | +37.6 |
| Q4 FY2022 | Dec 31, 2022 | -92.6% | +2.3 |
| Q3 FY2022 | Sep 30, 2022 | -105.0% | −28.2 |
| Q2 FY2022 | Jun 30, 2022 | -104.9% | +1.3 |
| Q1 FY2022 | Mar 31, 2022 | -146.8% | −11.4 |
| Q4 FY2021 | Dec 31, 2021 | -94.9% | −0.3 |
| Q3 FY2021 | Sep 30, 2021 | -76.8% | −40.4 |
| Q2 FY2021 | Jun 30, 2021 | -106.2% | +218.1 |
| Q1 FY2021 | Mar 31, 2021 | -135.4% | −52.2 |
| Q4 FY2020 | Dec 31, 2020 | -94.6% | −49.5 |
| Q3 FY2020 | Sep 30, 2020 | -36.4% | +11.2 |
| Q2 FY2020 | Jun 30, 2020 | -324.3% | −248.7 |
| Q1 FY2020 | Mar 31, 2020 | -83.1% | +22.9 |
| Q4 FY2019 | Dec 31, 2019 | -45.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -47.6% | – |
| Q2 FY2019 | Jun 30, 2019 | -75.6% | – |
| Q1 FY2019 | Mar 31, 2019 | -106.1% | – |
See a number that looks wrong?